15 January 2026 - trading update
The leading international developer and manufacturer of rapid diagnostic tests and med-tech has issued a trading update covering the six month period to 31 December and this has revealed that revenues have grown by 45% during the period to £4.5m - the increase has been driven by a number of of significant commercial contracts as well as grant-funded contract development revenue. The company raised £3.2m in October through an equity issue and at the end of the period it had cash of £3.6m. Revenues are set to increase in the second . . .
This content is restricted to members only. We offer three packages from 1 month to a whole year of daily tips, market news and commentary, plus our monthly newsletters.
Registration is quick and simple HERE.
Already a member, log in HERE.
